@article {5964,
	title = {Tumor markers in biological fluids associated with pregnancy},
	journal = {Critical Reviews in Clinical Laboratory Sciences},
	volume = {44},
	year = {2007},
	month = {2007///},
	pages = {151 - 178},
	abstract = {Proteins that are expressed by both malignant and healthy fetal tissues are recognized as oncofetal. These antigens are associated with cell proliferation and differentiation and are produced in high concentrations in pregnancy and malignancy. Their biological role in malignancy is the suppression of the host{\textquoteright}s immune system, while in pregnancy they affect the maternal immune response, generating maternal tolerance toward the embryo. This review describes the levels of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), carcinoembryonic antigen (CEA), cancer antigen 125 (CA 125), squamous cell carcinoma antigen (SCC), cancer antigen 15-3 (CA 15-3), mucin-like carcinoma-associated antigen (MCA), tissue polypeptide-specific antigen (TPS), carbohydrate antigen 19-9 (CA 19-9), and prostate-specific antigen (PSA) in maternal serum (MS), umbilical cord serum (UC), and amniotic fluid (AF) and outlines their roles in the assessment of pregnancy and malignancy. All antigens studied, except CA 15-3, are oncofetal. The presence of considerable concentrations of AFP, hCG, CEA, CA125, SCC, MCA, TPS, CA 19-9, and PSA in AF during pregnancy may be attributed to their involvement in biological functions associated with fetal development, differentiation, and maturation. MS CEA, CA 15-3, and CA 19-9, in contrast to all the others, are not influenced significantly by pregnancy and thus remain reliable tumor markers in monitoring malignancy in pregnant patients. Copyright {\textcopyright} 2007 Informa Healthcare.},
	keywords = {AFP, Amniotic fluid, CA 125, CA 15-3, CA 19-9, CEA, hCG, Maternal serum, MCA, Oncofetal antigens, Oncofetal proteins, PSA, SCC, TPS, Umbilical cord},
	author = {Sarandakou, A. and Protonotariou, E. and Rizos, D.}
}
